The global disruptive behavior disorder treatment market size is anticipated to expand at a substantial CAGR during the forecast period, 2021–2028. The growing demand of the market is attributed to the rising cases of behavioral disorders and growing development of various advanced treatment methods of the disorders.
Disruptive behavioral disorders refer to various type of mental disorder that are generally occurred in preschool and elementary school children. A child having such disorders usually shows aggressive behavior such as extreme outbursts and lengthy tantrums. Parents or guardian are facing difficulties in handling tough characters of such children, who are affected by abnormal functioning of their neurological system. Anger management is normally prescribed to help the children in dealing with cycles of anger and to control aggressive outbursts. Parent management training are also widely conducted to educate guardian and help develop a positive conduct reinforcement technique to control disruptive behavior of their children. Drug therapies including selective serotonin reuptake inhibitors for depressive signs and symptoms and temper stabilizers for situations including depression are extensively adopted to alleviate signs and symptoms from different comorbid psychiatric disorders.
As per a report by the National Institute of Mental Health, more than 44.7 million youth were reported to be suffering from severe mental health issues due to the lack of proper treatment at the primary stage in the US in 2016. There were nearly about 8 million American adults who had suffered from mental illness due to substance abuse, a report published by the Substance Abuse and Mental Health Services Administration (SAMHSA) in 2014.
The report on the global disruptive behavior disorder treatment market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes | Details |
Report Title | Disruptive Behavior Disorder Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year | 2020 |
Historic Data | 2018–2019 |
Forecast Period | 2021–2028 |
Segmentation | Types (Conduct Disorder, Oppositional Defiant Disorder, and Intermittent Explosive Disorder), Treatments (Comprehensive Evaluation, Parenting Modification, Individual Therapy, Medication Management, Family Therapy, Group Therapy, and Social & Emotional Skill Training) |
Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report | Highland Ridge Hospital; INTEGRIS Health; Jane Phillips Medical Center; Lakeview Health Addiction Treatment and Recovery; Eli Lilly and Company; Pfizer Inc.; Alliance Health Midwest Behavioral Health; Johnson & Johnson Services, Inc.; Boston Children's Hospital; and Springwoods Behavioral Health. |
Based on types, the global disruptive behavioral disorder treatment market is divided into conduct disorder, oppositional defiant disorder, and intermittent explosive disorder. The oppositional defiant disorder (ODD) registered a large revenue share in 2020 and is expected to hold a considerable share in the coming years due to rising cases of ODD among a large number of kids. In this case, children often argue and refuse to obey teachers, parents, or others. The most common behaviors that ODD patients include spitefulness, negativity, hostility, verbal aggression, and defiance.
According to the Apollo hospital, around 1 million people are getting affected by ODD globally per year. Innovative therapies and learning sessions are being conducted by various hospitals and medical treatment center to educate parents for effective handling of their children. For example, Newborn Behavioral Observations (NBO) system training program was conducted by Boston Children's Hospital for children and their parent on neuro-behavioral developments and building parent-child relationship. As per a report by the American Academy of Child & Adolescent Psychiatry, about 1% to 16% of youth and school-age children have this disorder and the condition is mainly diagnosed more in female rather than male.
On the basis of treatments, the market is segmented into comprehensive evaluation, parenting modification, individual therapy, medication management, family therapy, group therapy, and social & emotional skill training. The medication management segment is projected to expand at a considerable growth rate in the coming years owing to high demand for the treatment of oppositional defiant and behavior disorders medication management among parents who are aware of the disorders. In such cases, herbal and synthetic capsules are prescribed by doctors to parents for proper brain and nervous stimulation of their children. The prescription of such medication to children is not primarily recommended in the initial stage of treatment. Along with medication management, several other options are available for the treatment such as parenting modifications, organization sessions, and social-emotional competencies training, which are considered to more effective in some cases.
In terms of regions, the global disruptive behavioral disorder treatment market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to expand at a rapid pace during the forecast period owing to early adoption of advanced technology for the diagnostic devices and treatment as well as expansion of research to develop and discover better therapies. For example, over 150 years, Boston Children's Hospital has been actively participating various research activities to provide evidence-based therapies, treatments, and well-being of children. Moreover, high expenditure on healthcare industry from government bodies and increasing awareness related to mental health of children among parents are key drivers for the regional market growth. As per a report by the US Centers for Disease Control and Prevention (CDC), around 4.5 million adolescents are diagnosed with behavioral disorder problems every year.
On the other hand, the market of Asia Pacific is expected to register a major growth rate owing to increasing targeted population and growing substance abuse among teenage specifically in India and China. Moreover, gradual increase in the awareness of the disorder among a large number of parents in the region plays a crucial factor for the market expansion in Asia Pacific.
Key players in the global disruptive behavioral disorder treatment market are Highland Ridge Hospital; INTEGRIS Health; Jane Phillips Medical Center; Lakeview Health Addiction Treatment and Recovery; Eli Lilly and Company; Pfizer Inc.; Alliance Health Midwest Behavioral Health; Johnson & Johnson Services, Inc.; Boston Children's Hospital, and Springwoods Behavioral Health.
Many of these major companies are involved in developing new treatments and innovative know sessions, to bolster their position in the market. For example, Lakeview Health opened a brand new treatment center in Woodlands, Texas for treating drug dependency and psychiatric issues in January 2018. This center was established to focus particularly on taking care of medically underserved communities.
Some other reports from this category!